Stocktoria
Lifeward Ltd. LFWD
Lifeward Ltd. (LFWD) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2025 revenue was $22.0M at a -90.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.35 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| LFWD | Lifeward Ltd. | 4/9 | — | — | -14.1% |
| ZJYL | Jin Medical International Ltd. | 4/9 | 5.16 | 15.7 | -12% |
| MLSS | MILESTONE SCIENTIFIC INC. | 2/9 | — | — | — |
| MYO | MYOMO, INC. | 3/9 | -8.82 | — | +25.7% |
| FEED | ENvue Medical, Inc. | 2/9 | -6.2 | — | — |
| CLGN | CollPlant Biotechnologies Ltd | 3/9 | — | — | — |
| NTRB | NutriBand Inc. | 3/9 | -15.84 | — | — |
About Lifeward Ltd.
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.
FAQ
Is LFWD financially healthy?
Lifeward Ltd.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does LFWD pay a dividend?
No, Lifeward Ltd. does not currently pay a dividend.
How profitable is LFWD?
In FY2025, Lifeward Ltd. had a net margin of -90.4% and a return on equity of -236.8%.
What is the analyst price target for LFWD?
The average Wall-Street price target for Lifeward Ltd. is $20.00, about 158.1% above the recent price, from 2 analysts.
Is LFWD a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Lifeward Ltd.: a Piotroski F-score of 4/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.